pediatric neurologic pediatric neurologic
emergenciesemergencies
may 2002 core rounds
contentscontents
seizures
–approaches to
febrile seizure
new onset non-febrile seizure
established seizure disorder with recurrence
neonatal seizures
status epilepticus
–investigation, treatment, disposition
headache
–discussion (as little evidence to support)
migraine treatment
imaging indications
case 1case 1
2 year old
parents “shaking episode” lasting “10 mins”
EMS called - child no longer shaking
V/S - BP 105/60 HR 100 RR 18 Sat N T39
approach?
–well looking child
first event
multiple events
–sick looking child
case 2case 2
8 year old
parents describe good history for tonic-clonic activity
lasting 2 mins
1st event
post event confusion - improving
in ED - V/S N, N sensorium, N neuro exam
otherwise healthy, no meds, no allergies
approach?
case 3case 3
16 year old
known seizure disorder, on phenytoin
typical seizure presenting complaint
V/S N, neuro N, otherwise looks well
approach?
case 4case 4
2 week old
parents - “doesn’t look right”, “mouth opening and
closing”
one episode lasting 1 minute
child not interested in feeding, sleepy
V/S - BP 90/50 HR 130 RR 38 sat N T 37.8
otherwise normal exam
approach?
definitionsdefinitions
febrile seizure – NIH defn - event of
infancy/childhood, typically between age
3mo and 5yrs, with no evidence intracranial
infection or defined cause
epilepsy - two or more seizures not
provoked by a specific event such as fever,
trauma, infection, or chemical change
definitionsdefinitions
neonatal seizure – in first 28 days of life
(typically first few days)
status epilepticus
–seizure lasting >30 mins
NB rosen 5-10 mins
–sequential seizures without regain LOC >30min
classificationclassification
generalized
–LOC
–tonic, clonic, tonic-clonic, myoclonic, atonic, absence
partial – focal onset
–simple partial – no LOC
–complex partial – LOC
–partial secondarily generalized
unclassified
approach to febrile seizuresapproach to febrile seizures
the numbersthe numbers
epidemiology
–age 3mo – 5yrs
–peak age 9-20 mo
–2-5% children will have before age 5
–25-40% will have family history
–80 – 97% simple
–3 - 20% complex
simple febrile seizuresimple febrile seizure
< 15 mins
no focal features
no greater than 1 episode in 24h
neurologically and developmentally normal
complex febrile seizurecomplex febrile seizure
>15 min
–febrile epilepticus >30min or recurrent without
regaining consciousness > 30min
focal
recurrence within 24h
what do parents want to what do parents want to
know?know?
recurrence
–risk recurrence 25-50%
–risk recurrence after 2
nd
– 50%
–most recurrences within 6-12 mo
(20% within same febrile illness)
risk of epilepsy
–2-3% (baseline 1%)
–increased in
family history of epilepsy
abnormal developmental status
complex febrile seizure
neonatal seizureneonatal seizure
brief and subtle
–eye blinking
–mouth/tongue movements
–“bicycling” motion to limbs
typically sz’s can’t be provoked/consoled
autonomic changes
EEG less predictable
neonatal seizureneonatal seizure
etiology
–hypoxic-ischemic encephalopathy
Presents within first day
–congenital CNS anomalies
–intracranial hemorrhage
–electrolyte abnormalities – hypoglycemia and
hypocalcemia
–infections
–drug withdrawal
–pyrodoxine deficiency
status epilepticusstatus epilepticus
definition
–deizure lasting >30 mins
NB Rosen 5-10 mins
–sequential seizures without regain LOC >30min
mortality in pediatric status epilepticus 4%
morbidity may be as high as 30%
SE treatment considerationsSE treatment considerations
ABC’s
brief directed Hx and Px
glucose
antibiotics/antivirals
–if meningitis/encephalitis considered
lumbar puncturelumbar puncture
patients at greatest risk for meningitis
–under 18 months of age
–seizure in the ED
–focal or prolonged seizure
–seen a physician within the past 48 hours
other indications
–concern about follow-up
–prior treatment with antibiotics
The American Academy of Pediatrics
“strongly consider” in infants under 12 months of age with a first
febrile seizure
neuroimagingneuroimaging
WHO? which patients?
WHAT? CT vs. MRI
–ultrasound in neonates
WHEN? emergent vs. elective
ACEP guidelines - >6 yoACEP guidelines - >6 yo
consensus indication for non-contrast CT
first time seizure patients
–if suspect structural lesion
–partial onset seizure
–age > 40
–no other identified cause
recurrent seizure patients
–change in pattern
–prolonged post-ictal period
–worsening mental status
neuroimagingneuroimaging
predictors of abnormal findings of computed tomography of the head in
pediatric patients presenting with seizures
Warden CR - Ann Emerg Med - 01-Apr-1997; 29(4): 518-23
–retrospective case series
–predicts CT scan results normal if
no underlying high-risk condition
–malignancy, NCT, recent CHI, or recent CSF shunt revision
older than 6 months
sustained a seizure of 15 minutes or less
no new-onset focal neurologic deficit
–not prospectively validated
emergent EEG?emergent EEG?
not generally available on emergent basis
but consider in..
–persistent altered mental status (?non
convulsive status epilepticus)
–paralyzed patients
–pharmacologic coma
dispositiondisposition
can be discharged home if
–single seizure
–stable, returning to baseline neuro status
–no underlying condition/cause requiring
treatment in hospital
–arranged follow-up
EEG – 1EEG – 1
stst
non-febrile seizure non-febrile seizure
follow-up EEG
–within 24h
Lancet 1998;352:1007-11
improved pick-up 51% vs 34%
? how soon do we get ours ?
–inter-ictal EEG’s often normal
neuro may do sleep deprivation study (provocation)
–absence epilepsy and infantile spasms are invariably
associated with an abnormal EEG
–spike and wave 3HZ
neuroimagingneuroimaging
MRI superior
not emergently available
?defer imaging until follow-up MRI
available in low risk patients?
treatmenttreatment
correct underlying pathology, if any
antipyretics ineffective in febrile seizure
anti-epileptic choice often trial and error
no anti-epileptic 100% effective
febrile seizure – diazepam, phenobarbital, valproic acid
–Currently AAP does not recommend
neonatal - phenobarbital
generalized TC – phenytoin, phenobarbital, carbamazepine, valproic acid,
primidone
absence – ethosuximide, valproic acid
new anti-epileptics – felbamate, gabapentin, lamotrigine, topiramate,
tiagabine, vigabatrine
in consultation with neurologist
pediatric headachepediatric headache
case 5case 5
14 year old
mother’s chief complaint - “having headaches all the
time, getting worse, this is not normal!!” etc. etc……..
V/S N
looks in discomfort but otherwise well
approach?
–treatment
–imaging?
migraine treatmentmigraine treatment
very little supporting evidence for pharmacologic
treatment in children compared to adults
classes of medication
–acetaminophen
–NSAIDS
–phenothiazines (dopamine antagonists)
–dihydroergotamine
–triptans
the simple stuffthe simple stuff
acetaminophen 15 mg/kg PO 30mg/kg PR
ibuprofen 10 mg/kg PO
Hamalainen ML Ibuprofen or acetaminophen for the acute treatment
of migraine in children: A double-blind, randomized, placebo-
controlled, crossover study
Neurology 48:103-107, 1997
–N = 88 age 4-16
–relief at 2 hours
acetaminophen 54%
ibuprofen 68%
other NSAIDSother NSAIDS
naproxen 5-7 mg/kg PO
–no pediatric evidence
ketorolac IV 0.5 mg/kg (max 30mg dose)
–not studied in pediatric migraine
–not approved <16 yo
–Houck CS – Safety of intravenous ketorolac in children and cost savings with a unit
dosing system. J Pediatr - 01-Aug-1996; 129(2): 292-6
1747 children
0.2% hypersensitivity
0.1% renal complications (in patients with renal disease)
0.05% gi bleed
dihydroergotaminedihydroergotamine
not approved
?dose – 0.1 – 0.5 mg IV
not studied in emergency population
Linder SL – Treatment of childhood migraine with dihydroergotamine
mesylate Headache - 1994 Nov-Dec; 34(10): 578-80
–N = 30
–inpatient protocol
–IV DHE and PO metoclopramide – average 5 doses!
–80% response
phenothiazinesphenothiazines
again no studies
metoclopramide 1-2 mg/kg IV (max 10mg)
prochloperazine 0.1 – 0.15 mg/kg IV/IM/PO/PR
(max 10mg)
children may be more susceptible to EPS
–? pre-treat with benadryl
triptanstriptans
mostly studied in adolescent groups
sumitriptan subcutaneous 0.06mg/kg
–Linder S: Subcutaneous sumatriptan in the clinical setting: The first 50 consecutive
patients with acute migraine in a pediatric neurology office practice. Headache 36:419–
422, 1996
–N = 50 age 6-18
–78% effective at 2 hours
–6% recurrence
sumitriptan intranasal
–long term treatment studies done
–no emergent studies
triptans PO
–studies plagued by high placebo response
chronic progressive headachechronic progressive headache
least common presentation
most worrisome for increased ICP
–pseudotumor cerebri
–space occupying lesion
imaging indications? discussimaging indications? discuss
lack of evidence to help
–small studies lack power to guide decision
making
MRI preferred in non-urgent indication
imaging indications? discussimaging indications? discuss
classically based on historical and physical
–sudden severe headache
–rapid increase over days - weeks
–chronic progressive
–suggestive of increased ICP
severe nocturnal headache (wakes or upon waking), changes in pain with
position, coughing
–following head trauma
–persistent neuro findings
? include migraine equivalents ?
–growth abnormality
–age (? <3 ?)